PRELUDE CAPITAL MANAGEMENT, LLC - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 424 filers reported holding VANECK VECTORS ETF TR in Q4 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2023$2,977,672
+560.4%
110,653
+638.9%
0.19%
+569.0%
Q2 2023$450,897
-43.1%
14,975
-48.3%
0.03%
+31.8%
Q2 2022$793,000
-55.2%
28,961
-37.3%
0.02%
-56.9%
Q1 2022$1,771,000
+755.6%
46,188
+615.1%
0.05%
+920.0%
Q4 2021$207,000
-81.2%
6,459
-82.7%
0.01%
-82.8%
Q3 2021$1,102,000
+48.3%
37,392
+71.0%
0.03%
+31.8%
Q2 2021$743,000
+214.8%
21,869
+201.5%
0.02%
+266.7%
Q1 2021$236,000
-97.5%
7,254
-97.2%
0.01%
-97.5%
Q4 2020$9,437,000
+287.7%
262,008
+148.0%
0.24%
+47.2%
Q1 2020$2,434,000
-74.0%
105,638
-67.0%
0.16%
-54.2%
Q4 2019$9,361,000
+23.7%
319,704
+86.7%
0.36%
+4.4%
Q3 2019$7,567,000
+1723.4%
171,203
+955.2%
0.34%
+1605.0%
Q2 2019$415,000
-86.1%
16,225
-87.7%
0.02%
-88.2%
Q1 2019$2,982,000
+587.1%
132,225
+542.1%
0.17%
+482.8%
Q4 2018$434,000
-80.4%
20,591
-64.7%
0.03%
-77.5%
Q3 2018$2,216,000
+907.3%
58,400
+456.2%
0.13%
+377.8%
Q4 2016$220,000
+74.6%
10,500
+121.1%
0.03%
+107.7%
Q3 2016$126,0004,7500.01%
Other shareholders
VANECK VECTORS ETF TR shareholders Q4 2018
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$20,220,00066.82%
Baymount Management LP 145,000$3,970,00028.08%
New Harbor Financial Group, LLC 1,371,341$37,547,00018.51%
New Harbor Financial Group, LLC 1,291,700$35,366,00017.44%
MKP Capital Management, L.L.C. 1,500,000$41,070,00013.74%
Windmill Hill Asset Management Ltd 844,600$23,125,00011.94%
Hollow Brook Wealth Management LLC 768,567$21,043,00011.57%
Grand Central Investment Group 261,915$7,171,00010.33%
Point72 Europe (London) LLP 1,467,000$40,166,0008.50%
Slate Path Capital LP 4,600,000$125,948,0007.87%
View complete list of VANECK VECTORS ETF TR shareholders